https://orcid.org/0000-0002-2003-1512
Figures
Abstract
Background
A common complication of endovascular treatment for femoropopliteal lesions is bleeding at the vascular access site. Although risk factors of bleeding-associated complications at the approach site have been reported, the results have been inconclusive. Hence, this study aimed to assess the predictors of bleeding-associated complications at the approach site in patients undergoing endovascular treatment for femoropopliteal lesions.
Methods
This retrospective, single-center, observational study included consecutive patients who underwent endovascular treatment (n = 366, 75% male, 72.4±9.9 year) for peripheral arterial disease with claudication and critical limb ischemia in our hospital from January 2010 to December 2017. We divided the patients into bleeding and non-bleeding groups, depending on whether bleeding-associated complications occurred at the approach site. Bleeding-associated complications were defined according to the Bleeding Academic Research Consortium criteria types 2, 3, and 5.
Results
Altogether, 366 endovascular treatment procedures and 404 arterial accesses were performed for femoropopliteal lesions in 335 peripheral arterial disease patients with claudication and 69 critical limb ischemia patients. We recorded 35 postprocedural bleeding-associated complications at the approach site (9%), all of which were hematomas. The predictors of increased bleeding-associated complications were age ≥ 80 years (bleeding vs. non-bleeding group, 43% vs. 25%, p<0.05) and antegrade cannulation of the common femoral artery (48% vs. 69%, p<0.05). Ultrasound-guided puncture reduced bleeding-associated complications (odds ratio, 0.28; 95% confidence interval, 0.004–0.21; p<0.05). In contrast, there was no significant difference in puncture site calcification between the groups (bleeding vs. non-bleeding groups, 29% vs. 21%, p = 0.29).
Conclusion
Ultrasound-guided puncture is associated with a decrease in bleeding-associated complications at the approach site, regardless of the presence of calcified plaque. It is particularly effective and should be more actively used in patients aged ≥80 years and for antegrade cannulation of the common femoral artery.
Citation: Fukuda K, Okazaki S, Shiozaki M, Okai I, Nishino A, Tamura H, et al. (2021) Ultrasound-guided puncture reduces bleeding-associated complications, regardless of calcified plaque, after endovascular treatment of femoropopliteal lesions, especially using the antegrade procedure: A single-center study. PLoS ONE 16(3): e0248416. https://doi.org/10.1371/journal.pone.0248416
Editor: Xianwu Cheng, Nagoya University, JAPAN
Received: October 30, 2020; Accepted: February 26, 2021; Published: March 12, 2021
Copyright: © 2021 Fukuda et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the manuscript.
Funding: The author(s) received no specific funding for this work.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Endovascular treatment (EVT) for femoropopliteal (FP) lesions is currently one of the most rapidly expanding fields of medicine. According to the treatment recommendations for FP lesions in 2010 upon this study’s initiation, EVT was only recommended for single stenosis of <3 cm in patients with peripheral arterial disease (PAD) with claudication, and surgical intervention was the first choice for patients with other lesions and critical limb ischemia (CLI) [1]. In the past decade, new EVT-related devices and technologies have been introduced sequentially, and improvements in treatment results have been reported [2–7]. Regarding treatment recommendations for FP lesions in 2017 upon this study’s completion, EVT was the first choice for stenoses and occlusions of <25 cm in patients with claudication and CLI [8]. With this rapid development of EVT, treating more severe and advanced lesions became possible. In the future, EVT is expected to be developed further and treat more complicated cases than was previously possible. Conversely, complications have become more problematic than previously reported because high-risk patients are currently being targeted, and the reduction in complications is important.
One of the most common complications of EVT is bleeding complications at the vascular access site, with an incidence of 1–10% [9–11]. Identified risk factors include increasing age, the female sex, anticoagulant use, puncture without ultrasonographic guidance, a large sheath size, and manual compression [12–18]. Although various studies have reported on the risk factors, the results are inconclusive. Additionally, in previous studies showing that ultrasound-guided puncture is useful, many of the cases are of retrograde approaches. In modern EVT, the antegrade approach is often required [19], and the purpose was to retroactively confirm whether ultrasound guidance is effective in the recent EVT situation. Hence, this study aimed to examine the risk factors for bleeding complications in EVT of FP lesions using real clinical data from our institution.
Materials and methods
Study design and patients
This was a retrospective, single-center study. Altogether, 366 consecutive patients who underwent EVT for FP lesions at our institution from January 2010 to December 2017 were enrolled in this study. We divided the patients into the bleeding group (BG) for those with bleeding-associated complications and the non-bleeding group (NBG) for those without bleeding-associated complications, and examined the risk factors related to the complications. The study was conducted in accordance with the Helsinki Declaration of 1971, as revised in 1982. Written informed consent was obtained from all patients.
Inclusion and exclusion criteria
We included all patients who underwent EVT for PAD with claudication and CLI. Patients who underwent EVT performed through antegrade or retrograde common femoral artery (CFA), and popliteal artery or distal below-the-knee artery accesses were included, whereas those who underwent EVT using other accesses, such as the radial or brachial artery, were excluded.
Endpoints
We reviewed patient demographics, medical comorbidities, and operative details. The main outcome measure of bleeding-associated complications was defined as bleeding at the puncture site that required medical intervention (requiring compression, an extension of the bed rest period, transfusion, and operation for hemostasis), classified as Bleeding Academic Research Consortium criteria types 2, 3, and 5 [20].
Study participants and clinical assessment
PAD with claudication was diagnosed based on clinical symptoms of intermittent claudication and angiographic findings, which showed >75% stenosis and/or a translational pressure gradient (>20 mmHg) and was classified according to the Trans-Atlantic Inter-Society Consensus (TASC). Meanwhile, CLI was diagnosed based on clinical symptoms of ischemic pain at rest or the presence of tissue loss, such as in PAD-related non-healing ulcers or gangrene. Calcification at the puncture site was defined as a clear confirmation of calcification on a fluoroscopic image.
Endovascular intervention
Arterial puncture procedures were performed only by certified doctors. The needle aimed at the distal third of the femoral head, and only the anterior wall of the artery was punctured. Patients with normal renal function underwent angiography with iopamidol-370. Those with creatinine level >1.5 mg/dL underwent angiography with carbon dioxide. Heparin (5000 IU) was used in all patients to induce systemic anticoagulation. When the wire passed the culprit lesion, pre-dilation with either a plain balloon or scoring balloon angioplasty was performed. The balloon size was determined by the operator and was based on the angiographic appearance of the vessel. FP lesions were first treated with balloon angioplasty at a nominal pressure for 5 min, and a nitinol stent was introduced when major dissection with contrast delay occurred. In FP lesions, EVT success was defined as residual lesions <50%, without the occurrence of flow-limiting dissection. Protamine was used unless there was a known contraindication such as an allergy. If the puncture position did not involve the bifurcation, hemostasis was attempted using vascular closure devices. In either case, manual compression was performed for 15 min or more by a clinical fellow until hemostasis was achieved, and finally, mechanical compression was added using a tourniquet band. The patient was rested on a bed for 6 h or more after the operation, and walking was permitted after examination of the puncture site the next day.
Statistical analysis
Continuous variables are presented as mean±SD or median (interquartile range); categorical variables are presented as numbers and percentages. P-values <0.05 are considered statistically significant. Categorical variables are described as numbers and proportions and were analyzed using the chi-square test, whereas continuous variables were analyzed using the Student’s t-test. Multivariate analysis was performed using variables that were reportedly associated with access site complications. A stepwise multiple regression analysis was performed to determine the variables. All statistical analyses were performed using SPSS version 16.0 (SPSS Inc., Chicago, IL, USA) and JMP version 9.0.0. (SAS Institute Inc., Cary, NC, USA).
Results
Altogether, 374 EVT procedures were performed from January 2010 to December 2017. The patients’ ages ranged from 43 to 95 years (mean: 72.4±9.9 years). Among them, 303 were men (75%), 108 were ≥80 years (27%), 335 had PAD with claudication (83%), 69 had CLI (17%), 355 had hypertension (88%), 308 had dyslipidemia (76%), 250 had diabetes mellitus (62%), and 114 had undergone hemodialysis (28%) (Table 1).
Meanwhile, 412 arterial accesses from the CFA, popliteal artery, distal below-the-knee arteries, brachial artery, and radial artery were performed. We excluded seven arterial accesses from the brachial artery and one arterial access from the radial artery. Hence, 366 EVT and 404 arterial access procedures were included in this study. There were 35 bleeding-associated complications (9%), all of which were hematomas. Of the 35 patients with bleeding-associated complications, all required manual re-compression and extension of the bed rest period, and 15 patients were treated with blood transfusions and treated without sequelae. No cases required operation for hemostasis. The incidence of bleeding-associated complications was significantly high among patients aged ≥80 years (BG vs. NBG, 43% vs. 25%, p<0.05). There were no significant differences in the other contributing factors between the groups. The total number of dual antiplatelet therapy (DAPT) prescriptions was 335 (83%); however, the combination of oral antiplatelet drugs did not differ between the groups (BG vs. NBG, single antiplatelet therapy (SAPT): 9% vs. 4%, p = 0.14; DAPT: 77% vs. 83%, p = 0.34; SAPT + oral anticoagulant therapy (OAC): 3% vs. 5%, p = 0.63; DAPT + OAC: 9% vs. 8%, p = 0.83). There was no significant difference in the TASC classification (BG vs. NBG, TASC A and B: 46% vs. 41%, p = 0.58; TASC C and D: 54% vs. 59%, p = 0.58), chronic total occlusion (BG vs. NBG, 51% vs. 37%, p = 0.58), and puncture site calcification (BG vs. NBG, 29% vs. 21%, p = 0.29) between the groups (Table 1).
The most common arterial access site was the CFA in 89% (antegrade cannulation; n = 194 [48%], retrograde cannulation; n = 166 [41%]); the popliteal artery was selected in 43 (11%), and a distal below-the-knee artery was used in only one (0%). The used sheath size was 83% for ≥6 Fr and 17% for a sheath with <6 Fr or only a microcatheter. The ultrasound-guided puncture was performed in 168 patients (42%), and in the remaining patients, the fluoroscopy-guided or pulsation-guided puncture was performed. The treatment procedure was stent implantation (60%) and plain-old balloon angioplasty (35%) and did not involve a drug-eluting balloon or stent. For hemostasis, protamine was used in 61%, and vascular closure devices (Angio-Seal STS-Plus™ [St. Jude Medical, Minnesota, USA]/Exoseal™ [Cordis Corporation, Miami Lakes, FL, USA]) were used in 42% of the patients. The incidence of bleeding-associated complications was significantly higher with antegrade cannulation than with retrograde cannulation of the CFA (BG vs. NBG, 48% vs. 69%, p<0.05) and in the absence of ultrasound-guided puncture (3% vs. 45%, p<0.05). The incidence of bleeding-associated complications with ultrasound-guided puncture was 1% (1/168), and the incidence without ultrasound-guided puncture was 14.4% (34/236). In this study, 236 (58%) of the total 404 cases did not undergo ultrasound-guided puncture. If ultrasound-guided puncture was performed in all cases, the incidence of complications is expected to decrease from the actual 35 cases to 2.4 cases. Contralateral cannulation of the CFA (26% vs. 43%, p = 0.09), cannulation from the popliteal artery (6% vs. 11%, p = 0.32), and distal below-the-knee arteries (BG 0% vs. 0%) were not significantly different between both groups. There was no significant difference between the groups with respect to sheath size (p = 0.35), protamine use (69% vs. 61%, p = 0.36), or vascular closure devices (40% vs. 42%, p = 0.82) (Table 2).
Multivariable analysis of bleeding-associated complications
Table 3 demonstrates variables, including age ≥80 years, that were independently associated with increased odds of bleeding-associated complications after EVT (relative risk (RR), 2.04; odds ratio (OR), 2.82; 95% confidence interval (CI), 1.30–6.11; p<0.05). The use of real-time ultrasound-guided puncture was protective against bleeding-associated complications (RR, 0.04; OR, 0.28; 95% CI, 0.004–0.21; p<0.05).
Discussion
In this study, bleeding-associated complications after EVT occurred in 35 cases (9%). By re-verifying each factor, we found that bleeding events were very common among elderly people aged ≥80 years. Antegrade cannulation of the CFA and the lack of ultrasound-guided puncture were harmful as they caused bleeding events. Several previous studies have demonstrated that ischemia of the ipsilateral lower extremity is associated with hemostasis after femoral arterypuncture [18, 21]. Therefore, antegrade cannulation, which is a puncture of the lower limb on the lesion side, requires safe puncture without complications. Most of previous studies have demonstrated the usefulness of ultrasound-guided puncture; however, the rates of antegrade cannulation were as low as 0–16% [15, 16, 22, 23], which were not sufficient to evaluate the usefulness of ultrasound-guided puncture in antegrade cannulation. In this study, 48% of patients had antegrade cannulation, which indicates that ultrasound guidance is useful even in patients with a relatively high number of ipsilateral antegrade cannulations.
Previous studies have reported that patient predictors of bleeding-associated complications were increasing age and the female sex [12, 17]. Applegate RJ revealed that increasing age was associated with bleeding-associated complications (OR = 1.02, 95% CI 1.01–1.03, p<0.001) in 34,556 patients who underwent percutaneous cardiac catheterization via the CFA [24]. Especially in those aged ≥80 years, the risk of complication is higher [15]. In our patients, the age ≥ 80 years was a predictor of bleeding-associated complications.
Some studies reported procedural predictors of bleeding-associated complications, such as ultrasound-guided puncture [15, 16, 25], antegrade cannulation of CFA [26], sheath size [17, 27], and the use of vascular closure devices [11, 18, 28]. Although an ultrasound-guided puncture enables puncture at the calcified site to prevent bleeding-associated complications [22, 23], our study unexpectedly did not reveal an association between puncture site calcification and bleeding-associated complications. In contrast, routine ultrasound-guided punctures were protective against hematoma [15]. Hence, an ultrasound-guided puncture can not only avoid calcification but also enable puncture at an “optimal position,” thereby resulting in less plaque and potential hemostasis. There are several key points related to CFA puncture: 1) avoidance of the bifurcation site of the femoral artery, especially in cases involving a high takeoff deep femoral artery, 2) avoidance of the site where there is an overlap of the branch artery and the vein, 3) avoidance of a calcified lesion or plaque burden site in the CFA, and 4) identification of the position of the femoral head. Once the puncture position had been decided, the target vessel was punctured while checking the blood vessel and puncture needle simultaneously via ultrasonography. Bleeding-associated complications were reduced by appropriate puncturing based on information obtained by ultrasonography alone.
Antegrade cannulation of the CFA is also a predictor of bleeding-associated complications. Antegrade puncture is technically more difficult than a retrograde puncture. A high puncture (above the inguinal ligament) is associated with an increased incidence of groin hematoma and retroperitoneal bleeding [26]. Yeow et al. revealed that concomitant use of echo-guide puncture when performing antegrade cannulation of the CFA might reduce bleeding-associated complications [29]. In contrast, Siracuse et al. revealed that there were no significant differences between antegrade and retrograde cannulations in the overall rates of hematoma (3% vs. 2.7%; p = 0.21) or hematoma requiring intervention (0.4% vs. 0.4%; p = 0.75) in 45,816 patients undergoing EVT [19]. For antegrade cannulation, this is controversial.
The predictors of bleeding-associated complications such as the female sex, anticoagulant use, a large sheath size, and manual compression, identified in previous studies [12–18], were not significant in this study. The implication is that the increased risk due to these factors is offset by performing an “optimal puncture” with the ultrasound-guided puncture of the CFA.
This study had some limitations. First, it was a retrospective, single-center study. Second, the sample size was small. Third, multiple surgeons with different proficiencies were involved in the puncture and hemostasis; hence, the procedures may have been performed by surgeons with different experience levels.
Conclusions
EVT is expected to facilitate treatment for more complex and high-risk cases that could not be treated using previous techniques. Reducing complications is an important issue as high-risk patients are being increasingly targeted. Therefore, ultrasound-guided puncturing is recommended to reduce bleeding-associated complications, especially during antegrade cannulation of the CFA among elderly patients over the age of 80 years, regardless of calcified plaque at the puncture site.
References
- 1. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 Practice Guidelines for the Management of Patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery,* Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113: e463–e654. pmid:16549646
- 2. Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv. 2011;4: 495–504. pmid:21953370
- 3. Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, et al. Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial. Circulation. 2016;133: 1472–1483. pmid:26969758
- 4. Soga Y, Iida O, Hirano K, Yokoi H, Nanto S, Nobuyoshi M. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent. J Vasc Surg. 2010;52: 608–615. pmid:20573476
- 5. Dominguez A III, Bahadorani J, Reeves R, Mahmud E, Patel M. Endovascular therapy for critical limb ischemia. Expert Rev Cardiovasc Ther. 2015;13: 429–444. pmid:25728744
- 6. Menard MT, Farber A. The BEST-CLI trial: a multidisciplinary effort to assess whether surgical or endovascular therapy is better for patients with critical limb ischemia. Semin Vasc Surg. 2014;27: 82–84. pmid:25812762
- 7. Popplewell MA, Davies H, Jarrett H, Bate G, Grant M, Patel S, et al. Bypass versus angioplasty in severe ischaemia of the leg—2 (BASIL-2) trial: study protocol for a randomised controlled trial. Trials. 2016;17: 11. pmid:26739146
- 8. Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39: 763–816. pmid:28886620
- 9. Castillo-Sang M, Tsang AW, Almaroof B, Cireddu J, Sferra J, Zelenock GB, et al. Femoral artery complications after cardiac catheterization: a study of patient profile. Ann Vasc Surg. 2010;24: 328–335. pmid:19748217
- 10. Das R, Ahmed K, Athanasiou T, Morgan RA, Belli AM. Arterial closure devices versus manual compression for femoral haemostasis in interventional radiological procedures: a systematic review and meta-analysis. Cardiovasc Intervent Radiol. 2011;34: 723–738. pmid:21046386
- 11. Smilowitz NR, Kirtane AJ, Guiry M, Gray WA, Dolcimascolo P, Querijero M, et al. Practices and complications of vascular closure devices and manual compression in patients undergoing elective coronary procedures. Am J Cardiol. 2012;110: 177–182. pmid:22482861
- 12. Gewalt SM, Helde SM, Ibrahim T, Mayer K, Schmidt R, Bott-Flügel L, et al. Comparison of vascular closure devices versus manual compression after femoral artery puncture in women. Circ Cardiovasc Interv. 2018;11: e006074. pmid:30354782
- 13. Minko P, Katoh M, Gräber S, Buecker A. Obesity: an independent risk factor for insufficient hemostasis using the AngioSeal vascular closure device after antegrade puncture. Cardiovasc Intervent Radiol. 2012;35: 775–778. pmid:21792734
- 14. Kerneis M, Gibson CM, Chi G, Mehran R, Al Khalfan F, Talib U, et al. Effect of procedure and coronary lesion characteristics on clinical outcomes among atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI Trial. JACC Cardiovasc Interv. 2018;11: 626–634. pmid:29550085
- 15. Kalish J, Eslami M, Gillespie D, Schermerhorn M, Rybin D, Doros G, et al. Routine use of echo guidance in femoral arterial access for peripheral vascular intervention decreases groin hematoma rates. J Vasc Surg. 2015;61: 1231–1238. pmid:25595399
- 16. Seto AH, Abu-Fadel MS, Sparling JM, Zacharias SJ, Daly TS, Harrison AT, et al. Real-time echo guidance facilitates femoral arterial access and reduces vascular complications: FAUST (Femoral Arterial Access With Echo Trial). JACC Cardiovasc Interv. 2010;3: 751–758. pmid:20650437
- 17. Sharma V, Wilson W, Smith W, McEntegart M, Oldroyd K, Sidik N, et al. Comparison of characteristics and complications in men versus women undergoing chronic total occlusion percutaneous intervention. Am J Cardiol. 2017;119: 535–541. pmid:27923460
- 18. Dahal K, Rijal J, Shahukhal R, Sharma S, Watti H, Azrin M, et al. Comparison of manual compression and vascular hemostasis devices after coronary angiography or percutaneous coronary intervention through femoral artery access: a meta-analysis of randomized controlled trials. Cardiovasc Revasc Med. 2018;19: 151–162. pmid:28941744
- 19. Siracuse J, Farber A, Cheng TW, Raulli SJ, Jones DW, Kalish JA, et al. Common femoral artery antegrade and retrograde approaches have similar access site complications. J Vasc Surg. 2019;69: 1160–1166. pmid:30527937
- 20. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123: 2736–2747. pmid:21670242
- 21. Hanna N, Fiorilli P, Gaglia M, Torguson R, Vita A, Ben-dor I, et al. Low-Dose Protamine to Facilitate Earlier Sheath Removal from the FemoralArtery After Peripheral Endovascular. Journal of Interventional Cardiology. 2011; 24: 278–284. pmid:21535150
- 22. Sherev DA, Shaw RE, Brent BN. Angiographic predictors of femoral access site complications: implication for planned percutaneous coronary intervention. Catheter Cardiovasc Interv. 2005;65: 196–202. pmid:15895402
- 23. Toggweiler S, Gurvitch R, Leipsic J, Wood DA, Willson AB, Binder RK, et al. Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol. 2012;59: 113–118. pmid:22222073
- 24. Applegate RJ, Sacrinty MT, Kutcher MA, Kahl FR, Gandhi SK, Santos RM, et al. Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007. JACC Cardiovasc Interv. 2008;1: 317–326. pmid:19463320
- 25. Fujihara M, Haramitsu Y, Ohshimo K, Yazu Y, Izumi E, Higashimori A, et al. Appropriate hemostasis by routine use of echo ultrasound-guided transfemoral access and vascular closure devices after lower extremity percutaneous revascularization. Cardiovasc Interv Ther. 2017;32: 233–240. pmid:27430637
- 26. Looby S, Keeling AN, McErlean A, Given MF, Geoghegan T, Lee MJ. Efficacy and safety of the angioseal vascular closure device post antegrade puncture. Cardiovasc Interv Radiol. 2008;31: 558–562. pmid:18253787
- 27. Chung R, Weller A, Morgan R, Belli AM, Ratnam L. Are complication rates lower with 4-Fr versus 6-Fr transfemoral arterial access—prospective audit at a single interventional radiology centre. CVIR Endovasc. 2018;1: 15. pmid:30652147
- 28. Schulz-Schüpke S, Helde S, Senta S, Ibrahim T, Linhardt M, Haas K, et al. Comparison of vascular closure devices vs manual compression after femoral artery puncture. The ISAR-CLOSURE randomized clinical trial. JAMA. 2014;312: 1981–1987. pmid:25399273
- 29. Yeow KM, Toh CH, Wu CH, Lee RY, Hsieh HC, Liau CT, et al. Sonographically guided antegrade common femoral artery access. J Echo Med. 2002;21: 1413–1416. pmid:12494984